NestlÃ© Health Science and the pharmaceutical and healthcare group Chi-Med have agreed to form a 50/50 joint venture to be named Nutrition Science Partners Limited. NSP will research, develop, manufacture and market innovative nutritional and medicinal products derived from plants. The new partnership will give NestlÃ© Health Science access to one of the leading Traditional Chinese Medicine libraries. NSP will focus on gastrointestinal health and may expand into metabolic disease and brain health. The new partnership will build on NestlÃ© Health Science’s ambition to explore personalized health care combining nutrition, drugs and diagnostics. NestlÃ© Health Science has made a number of investments in its gastrointestinal portfolio, including a minority stake in Vital Foods of New Zealand and the acquisition of CM&D Pharma Ltd. NSP will be funded primarily through the initial NestlÃ© Health Sciences capital investment and milestone payments linked to the success of clinical and commercial activities.
Disclaimer: NCN does not warrant the accuracy, reliability, or timeliness of any NCN news item. Before relying on any NCN News item the information should be independently verified.
For more finance and investment information, visit Nutrition Capital Network news